Wright Medical's Q2 net income plunges; Vayar Imaging pulls in $12M for breast cancer Dx;

 @FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev

 @MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce

 @DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce

> Orthopedic devicemaker Wright Medical reported a 7% drop in sales for the second quarter, with net income tumbling to $700,000 from $6.1 million in the same period last year. Article

> Israeli startup Vayyar Imaging has raised $12 million in venture capital to fund its breast cancer diagnostics. News

> Diagnostics firm Metabolon has completed its acquisition of Lipomics, looking to combine that company's profiling lipids technology with its diabetes assay. More

> Medtronic ($MDT) CEO Omar Ishrak has taken to Twitter to spread his company's message. Story

> Smith & Nephew ($SNN), a maker of artificial hips and knees, raised its dividend 50% and will increase the payout in line with earnings growth. Story

> Baxter International ($BAX) broke ground on a new $1 billion manufacturing facility near Covington, GA. Story

Biotech News

 @FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech

 @JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce

 @RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce

> R&D shift sees new jobs in China as Western ops are restructured. Article

> Report: Bristol exec nabbed on insider trading charge. Item

> Halozyme blitzed as FDA rejects Baxter drug, halts combo trial. Story

> Analyst reads last rites after heart failure scuttles Bristol hep C study. News

Pharma News

 @FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma

> Gilead inks low-cost HIV drug deal with generics makers. News

> Sanofi, Otsuka amp up their Turkish ambitions. Story

> Glass Lewis stands up for Forest's board slate. Article

Vaccines News

> Old whooping cough vax more effective than new. News

> AstraZeneca wins Fluenz contract in U.K. Article

> Survey: U.S. females fail to finish Merck and GSK HPV shots. More

> NIH awards $5M for heroin addiction, AIDS vaccine. News

> Alnylam gets $3.2M milestone from GSK for vax tech. Story

Pharma Manufacturing News 

> Hospira CEO Ball says it's getting 'gators' under control. Report

> Rexam eyes factory growth, despite lagging healthcare sales. More

> CMC nabs Xoma's Bay Area plant. Article

And Finally... More U.S. women appear to be choosing intrauterine devices for birth control, according to a national survey. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.